The pharmaceutical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike injections, this approach offers a more convenient way to deliver GLP-1 medications. These transdermal systems gradually release the treatment through the epiderm